← Insider buys
HALO

Halozyme Therapeutics, Inc. · Healthcare

Director James M Daly sold $419K of Halozyme Therapeutics, Inc.

Sold$418,800
$40.41Price
10,363Shares
−33%Stake

What HALO did after the filing

Prices for HALO after this filing aren't in yet.

Traded Wed, Nov 25. Filed Wed, Nov 25, 6:57 PM ET, after the close. Not investment advice.